Search results
Why ‘free-from’ foods could be doing you more harm than good
Daily Telegraph· 6 days agoWhether you seek it out or stumble across it, no supermarket is without one; the free-from foods...
The Forgotten Stock Advice That Delivers 170%+ Payout Growth
Forbes· 1 day agoOne of the best ways to grab a dividend payer set to surge is a strategy you never hear about...
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 7 days agoZoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the...
Update: Kanawha has some of 152 people 'potentially exposed' to measles
The Charleston Gazette· 6 days agoKanawha County residents are among the scores of people in 30 West Virginia counties who might have...
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
FierceBiotech· 21 hours agoEli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also...
US opens COVID vaccine to little kids, shots begin next week
AOL· 2 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Serogroup B Invasive Meningococcal Disease in Older Adults Identified by Genomic Surveillance,...
Centers for Disease Control and Prevention· 6 days agoCases of invasive meningococcal disease (IMD) have declined in England, from 2,595 in 2000 to 205 in 2022 (1). During 2021–2022, a total of 89% of IMD cases occurred in persons <25 years of ...
Crimean Congo Hemorrhagic Fever Virus for Clinicians—Virology, Pathogenesis, and Pathology
Centers for Disease Control and Prevention· 6 days agoCCHFV—Virology, Pathogenesis, and Pathology
The New York Jets Go on the Offense at the Lupus Research Alliance 2024 New Jersey "Walk with Us to...
FOX 5 San Diego· 18 hours agoNearly 1,500 supporters will help tackle lupus this Saturday, May 4, for the Lupus Research Alliance (LRA) 2024 New Jersey Walk with Us to Cure Lupus at MetLife Stadium. Together ...
Amgen investors await weight-loss drug data
AOL· 23 hours agoAmgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We are still collecting and analyzing the ...